IP Library › Assignment 031144/0967
Patent Assignment
Reel/Frame 031144/0967

Assignment of Assignor's Interest

Recorded: 2013-09-05 Pages: 11
Assignors
REYNOLDS, JOSEPH G.
Executed: 2013-09-03
OLIVIER, KENNETH J., JR.
Executed: 2013-08-28
HENDRIKS, BART S.
Executed: 2013-09-03
WICKHAM, THOMAS
Executed: 2013-09-03
KLINZ, STEPHAN
Executed: 2013-08-28
GERETTI, ELENA
Executed: 2013-09-03
Assignee
MERRIMACK PHARMACEUTICALS, INC.
ONE KENDALL SQUARE, SUITE B7201, CAMBRIDGE, MASSACHUSETTS, 02139-1670
Covered Property (1)
Dosage and Administration for Preventing Cardiotoxicity in Treatment with ERBB2-Targeted Immunoliposomes Comprising Anthracyclin Chemotherapeutic Agents
Patent: 9,226,966 →
Application: 13/912,167 →
Publication: US 2014/0023698
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest Dec 28, 2015
From: MERRIMACK PHARMACEUTICALS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 037394/0285 →
Release of Security Interest Apr 14, 2017
From: U.S. BANK NATIONAL ASSOCIATION
To: MERRIMACK PHARMACEUTICALS, INC.
Reel/Frame 042254/0349 →